BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24930755)

  • 1. Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma.
    Murgod VV; Kale AD; Angadi PV; Hallikerimath S
    J Oral Sci; 2014 Jun; 56(2):173-8. PubMed ID: 24930755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
    Shraddha KS; Niranjan KC; Hallikeri K
    J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
    Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
    J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
    Angadi PV; Krishnapillai R
    Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
    Sudha VM; Hemavathy S
    Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
    Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
    J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Stage Oral Submucous Fibrosis is Characterized by Increased Vascularity as Opposed to Advanced Stages.
    Tekade SA; Chaudhary MS; Tekade SS; Sarode SC; Wanjari SP; Gadbail AR; Wanjari PV; Gawande MN; Korde-Choudhari S; Zade P
    J Clin Diagn Res; 2017 May; 11(5):ZC92-ZC96. PubMed ID: 28658917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
    Sarode SC; Sarode GS
    Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of β1integrin in normal epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
    Veeravarmal V; Austin RD; Nagini S; Nassar MHM
    Pathol Res Pract; 2018 Feb; 214(2):273-280. PubMed ID: 29113685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
    Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
    Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral submucous fibrosis: An enigmatic morpho-insight.
    Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
    J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silver-binding nucleolar organizer region proteins as a possible prognostic indicator in oral submucous fibrosis.
    Rajendran R; Nair SM
    Oral Surg Oral Med Oral Pathol; 1992 Oct; 74(4):481-6. PubMed ID: 1408025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of CD34 and basic fibroblast growth factor (bFGF) in oral submucous fibrosis.
    Pandiar D; Shameena P
    J Oral Maxillofac Pathol; 2014 May; 18(2):155-61. PubMed ID: 25328292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative Assessment of Collagen and Elastic Fibers in Oral Submucous Fibrosis (OSMF), OSMF with Dysplasia and Oral Squamous Cell Carcinoma Arising from OSMF: A Histochemical Study.
    Pandiar D; Aswani E; Krishnan RP
    Head Neck Pathol; 2023 Dec; 17(4):932-939. PubMed ID: 37843734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.
    Silva LC; Fonseca FP; Almeida OP; Mariz BA; Lopes MA; Radhakrishnan R; Sharma M; Kowalski LP; Vargas PA
    Med Oral Patol Oral Cir Bucal; 2020 Jan; 25(1):e49-e55. PubMed ID: 31880289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-3 expression in normal oral epithelium, oral submucous fibrosis and oral squamous cell carcinoma.
    Veeravarmal V; Austin RD; Siddavaram N; Thiruneelakandan S; Nassar MH
    J Oral Maxillofac Pathol; 2016; 20(3):445-452. PubMed ID: 27721610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
    Choudhari S; Masne S; Bhandare P; Dhumal S
    J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
    Nandakumar A; Nataraj P; James A; Krishnan R; K M M
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Immunolocalization of Mast Cells in the Pathology of Oral Submucous Fibrosis.
    Gupta S; Sharma M; Banerjee S; Holikatti K; Kamble P; Goyal JV
    Cureus; 2023 Jun; 15(6):e40069. PubMed ID: 37425595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.